Daniel R Weinberger Selected Research

Schizophrenia (Dementia Praecox)

1/2022	Mapping genomic loci implicates genes and synaptic biology in schizophrenia.
1/2022	Molecular phenotypes associated with antipsychotic drugs in the human caudate nucleus.
1/2022	Electrophysiological measures from human iPSC-derived neurons are associated with schizophrenia clinical status and predict individual cognitive performance.
1/2021	Developmental Profile of Psychiatric Risk Associated With Voltage-Gated Cation Channel Activity.
1/2021	Single molecule in situ hybridization reveals distinct localizations of schizophrenia risk-related transcripts SNX19 and AS3MT in human brain.
1/2021	Genome-wide sequencing-based identification of methylation quantitative trait loci and their role in schizophrenia risk.
1/2021	Identifying nootropic drug targets via large-scale cognitive GWAS and transcriptomics.
12/2020	Association of Missense Mutation in FOLH1 With Decreased NAAG Levels and Impaired Working Memory Circuitry and Cognition.
11/2020	Nimodipine improves cortical efficiency during working memory in healthy subjects.
7/2020	Special Article: Translational Science Update. Pharmacological Implications of Emerging Schizophrenia Genetics: Can the Bridge From 'Genomics' to 'Therapeutics' be Defined and Traversed?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel R Weinberger Research Topics

Disease

148	Schizophrenia (Dementia Praecox) 01/2022 - 02/2002
19	Psychotic Disorders (Schizoaffective Disorder) 11/2020 - 03/2003
17	Mental Disorders (Mental Disorder) 03/2022 - 11/2004
11	Cognitive Dysfunction 01/2020 - 01/2007
8	Bipolar Disorder (Manic Depressive Psychosis) 01/2021 - 05/2003
8	Mood Disorders (Mood Disorder) 01/2020 - 07/2004
6	Parkinson Disease (Parkinson's Disease) 09/2013 - 02/2002
4	Neurodevelopmental Disorders 01/2022 - 08/2010
3	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 10/2014
3	Genetic Predisposition to Disease (Genetic Predisposition) 10/2007 - 04/2003
2	Memory Disorders (Memory Loss) 01/2016 - 08/2008
2	Neurobehavioral Manifestations 08/2014 - 04/2014
2	DiGeorge Syndrome (Syndrome, DiGeorge) 03/2014 - 11/2008
2	Alzheimer Disease (Alzheimer's Disease) 01/2013 - 08/2012
2	Substance-Related Disorders (Drug Abuse) 01/2009 - 01/2008
2	Neoplasms (Cancer) 12/2007 - 08/2007
2	Classical Lissencephalies and Subcortical Band Heterotopias 04/2006 - 01/2006
2	Fasciculation (Fasciculations) 04/2006 - 01/2006
2	Hyperkinesis 05/2003 - 04/2002
1	Genetic Risk Score 01/2022
1	Tobacco Use Disorder (Nicotine Dependence) 01/2020
1	Brain Injuries (Brain Injury) 12/2019
1	Inflammation (Inflammations) 12/2019
1	Infections 12/2019
1	Atrophy 10/2018
1	Disease Progression 01/2018
1	Nervous System Diseases (Neurological Disorders) 01/2017

Drug/Important Bio-Agent (IBA)

29	Dopamine (Intropin)FDA LinkGeneric 01/2018 - 02/2002
26	Messenger RNA (mRNA)IBA 12/2020 - 08/2003
24	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 10/2002
20	Biological ProductsIBA 01/2021 - 02/2002
19	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2002
19	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2016 - 08/2003
16	Protein Isoforms (Isoforms)IBA 01/2021 - 02/2006
13	gamma-Aminobutyric Acid (GABA)IBA 01/2019 - 07/2003
11	Pharmaceutical PreparationsIBA 01/2021 - 10/2002
9	RNA (Ribonucleic Acid)IBA 03/2022 - 08/2010
9	DysbindinIBA 01/2016 - 06/2004
8	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2016 - 11/2004
8	Neuregulin-1 (Neuregulin 1)IBA 01/2016 - 01/2005
7	EnzymesIBA 03/2014 - 10/2002
6	Olanzapine (Zyprexa)FDA Link 01/2019 - 08/2004
5	NeuregulinsIBA 01/2017 - 08/2010
5	Amphetamine (Amfetamine)FDA LinkGeneric 01/2016 - 05/2003
5	Protons (Proton)IBA 01/2016 - 03/2003
4	metabotropic glutamate receptor 3 (mGluR3)IBA 12/2020 - 01/2005
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 03/2005
4	Glutamic Acid (Glutamate)FDA Link 07/2015 - 08/2004
3	Potassium Channels (Potassium Channel)IBA 01/2021 - 11/2016
3	Nicotine FDA Link 01/2020 - 02/2004
3	Nerve Growth Factors (Neurotrophins)IBA 01/2017 - 01/2013
3	N-Methylaspartate (NMDA)IBA 07/2015 - 09/2006
3	3' Untranslated Regions (3' UTR)IBA 03/2014 - 06/2004
3	DNA (Deoxyribonucleic Acid)IBA 10/2012 - 02/2008
3	N-acetylaspartate (N-acetyl aspartate)IBA 04/2006 - 03/2003
2	CationsIBA 01/2021 - 04/2014
2	Calcium Channels (Calcium Channel)IBA 01/2021 - 09/2010
2	MethyltransferasesIBA 01/2021 - 01/2007
2	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2020 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2008
2	Phosphotransferases (Kinase)IBA 01/2019 - 10/2017
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016 - 03/2012
2	Clozapine (Clozaril)FDA LinkGeneric 08/2014 - 08/2003
2	NucleotidesIBA 08/2014 - 06/2004
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 08/2014 - 10/2002
2	Indicators and Reagents (Reagents)IBA 03/2014 - 04/2013
2	Proline Oxidase (Proline Dehydrogenase)IBA 03/2012 - 11/2008
2	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 05/2011 - 10/2002
2	valylvaline (Val-Val)IBA 07/2010 - 11/2004
2	Valine (L-Valine)FDA Link 02/2010 - 03/2003
2	Estrogen Receptor alphaIBA 08/2008 - 10/2007
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2008 - 09/2006
2	methionylmethionine (Met-Met)IBA 12/2006 - 11/2004
2	GTP-Binding Proteins (G-Protein)IBA 09/2006 - 07/2006
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 05/2006 - 02/2005
2	ElementsIBA 04/2006 - 01/2006
2	salicylhydroxamic acid (SHAM)IBA 07/2003 - 04/2002
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	Sp4 Transcription FactorIBA 01/2022
1	CalciumIBA 01/2021
1	hydrogen sulfite (bisulfite)IBA 01/2021
1	ArsenicIBA 01/2021
1	Nootropic Agents (Nootropics)IBA 01/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2020
1	Nimodipine (Modus)FDA LinkGeneric 11/2020
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 11/2020
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2020
1	Dronabinol (THC)FDA LinkGeneric 01/2020
1	EndocannabinoidsIBA 01/2020
1	Ethanol (Ethyl Alcohol)IBA 01/2020
1	Sorting NexinsIBA 01/2020
1	CytokinesIBA 12/2019
1	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2019
1	Protein Kinase CIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Protein Kinases (Protein Kinase)IBA 10/2017

Therapy/Procedure

8	Therapeutics 07/2020 - 02/2002
2	Genomic Medicine 01/2019 - 10/2017
1	Prenatal Care (Care, Prenatal) 12/2019